Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) ...

Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial ...

In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

Research on hormone therapy reveals critical insights into cardiovascular disease risks, guiding clinicians in selecting ...

A study reveals women with hypertensive disorders of pregnancy have a higher risk of coronary artery disease and myocardial ...

Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is ...

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...

Evidence highlights the predictive value of the stress hyperglycemia ratio for mortality risk in patients with acute ...

This study presents useful albeit preliminary findings on transcriptome changes in cardiac lymphatic cells after myocardial infarction in mice. Despite revision, the conclusions of the authors remain ...